{"id":"hutox-inj","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or bruising"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Facial asymmetry or drooping"},{"rate":null,"effect":"Temporary muscle weakness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Hutox works by cleaving SNARE proteins required for acetylcholine vesicle fusion and release at motor nerve terminals. This leads to temporary paralysis of injected muscles, reducing dynamic wrinkles and muscle hyperactivity. The effect is reversible as new neuromuscular junctions form over several months.","oneSentence":"Hutox is a botulinum toxin type A preparation that blocks acetylcholine release at the neuromuscular junction to reduce muscle contractions.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:47:25.834Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Facial wrinkles and dynamic expression lines (aesthetic indication)"},{"name":"Muscle hyperactivity disorders (therapeutic indication)"}]},"trialDetails":[{"nctId":"NCT04081402","phase":"PHASE3","title":"A Phase 1/3 Clinical Trial to Evaluate the Safety and Efficacy of HUTOX Compared to Botox® in Subjects With Moderate to Severe Crow's Feet Lines","status":"UNKNOWN","sponsor":"Huons Co., Ltd.","startDate":"2018-11-01","conditions":"Crow's Feet Lines","enrollment":290},{"nctId":"NCT03440671","phase":"PHASE3","title":"The Safety and Efficacy Study of Hutox Versus Botox® in Subject With Moderate to Severe Glabellar Lines","status":"UNKNOWN","sponsor":"Huons Co., Ltd.","startDate":"2017-11-30","conditions":"Glabellar Frown Lines","enrollment":260}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":799,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Hutox Inj","genericName":"Hutox Inj","companyName":"Huons Co., Ltd.","companyId":"huons-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"Hutox is a botulinum toxin type A preparation that blocks acetylcholine release at the neuromuscular junction to reduce muscle contractions. Used for Facial wrinkles and dynamic expression lines (aesthetic indication), Muscle hyperactivity disorders (therapeutic indication).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}